Vitting-Seerup, Kristoffer
62  Ergebnisse:
Personensuche X
?
1

Most protein domains exist as variants with distinct functi..:

Vitting-Seerup, Kristoffer
https://orbit.dtu.dk/en/publications/27254243-b39e-41b4-b439-4fcbfa58b1d8.  , 2023
 
?
2

Expression and splicing mediate distinct biological signals:

Dam, Søren Helweg ; Olsen, Lars Rønn ; Vitting-Seerup, Kristoffer
https://orbit.dtu.dk/en/publications/8c9697dd-128d-4717-9bfd-22e14cb81ac2.  , 2023
 
?
5

Assessment of CD19 exon 2 abundance as a proxy for CD19delt..:

Dam, Søren Helweg ; Bogetofte Barnkob, Mike ; Vitting-Seerup, Kristoffer
Dam , S H , Bogetofte Barnkob , M & Vitting-Seerup , K 2022 , ' Assessment of CD19 exon 2 abundance as a proxy for CD19delta expression and prediction of anti-CD19 CAR therapy relapse ' , 10th Annual Immuno-Oncology Summit , Boston , United States , 12/10/2022 - 14/10/2022 ..  , 2022
 
?
6

PTBP1 promotes hematopoietic stem cell maintenance and red ..:

Rehn, Matilda ; Wenzel, Anne ; Frank, Anne-Katrine...
https://orbit.dtu.dk/en/publications/7665ab45-3a55-4327-a697-70ff93e94700.  , 2022
 
?
9

satuRn:Scalable analysis of differential transcript usage f..:

Gilis, Jeroen ; Vitting-Seerup, Kristoffer ; Van den Berge, Koen.
https://orbit.dtu.dk/en/publications/d91a9f7a-f598-45c5-a7c8-45d62146b609.  , 2022
 
?
10

Progression of the pluripotent epiblast depends upon the NM..:

Chousal, Jennifer N ; Sohni, Abhishek ; Vitting-Seerup, Kristoffer...
https://orbit.dtu.dk/en/publications/db06c95f-29e3-47b5-a214-64f457c51286.  , 2022
 
?
 
?
12

Editorial:Alternative Splicing in Health and Disease:

Kahraman, Abdullah ; Buljan, Marija ; Vitting-Seerup, Kristoffer
https://orbit.dtu.dk/en/publications/208de88e-28f1-45b1-a247-2a323a4d78d4.  , 2022
 
?
13

Target isoforms are an overlooked challenge and opportunity..:

Barnkob, Mike Bogetofte ; Vitting-Seerup, Kristoffer ; Olsen, Lars Rønn
Barnkob , M B , Vitting-Seerup , K & Olsen , L R 2022 , ' Target isoforms are an overlooked challenge and opportunity in chimeric antigen receptor cell therapy ' , Immunotherapy Advances , vol. 2 , no. 1 , ltac009 . https://doi.org/10.1093/immadv/ltac009.  , 2022
 
1-15